Kerry Group plc

Kerry Group plc

KRYAF
Kerry Group plcUS flagOther OTC
81.42
USD
-4.27
- -
13.01BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
33.22
32.75
34.71
34.83
36.33
37.39
40.96
39.28
41.48
49.45
39.32
40.05
41.07
Basic EPS, GAAP
0.48
2.73
2.99
3.03
3.34
3.06
3.2
3.13
4.31
3.42
4.1
4.25
4
Free Cash Flow per Basic Share
1.55
1.16
2.69
2.63
2.13
1.96
2.54
2.22
2.01
2.82
4.26
3.95
3
Dividend per Share
0.37
0.42
0.47
0.52
0.58
0.65
0.73
0.81
0.89
0.98
1.08
1.19
1.31
Book Value per Share
9.91
11.02
14.19
15.87
19.21
21.75
24.22
26.19
30.09
32.46
34.76
25.44
35.28
Tangible Book Value per Share
-2.42
-2.24
-3.94
-1.99
-0.42
-0.35
-0.16
-0.18
0.12
2.84
4.36
4.1
3.1
Basic Weighted Avg Shares
176
176
176
176
176
177
177
177
177
177
177
173
165
Sales/Revenue/Turnover
5,837
5,757
6,105
6,131
6,408
6,608
7,241
6,953
7,351
8,772
6,975
6,929
6,758
Operating Margin (%)
9.88
10.66
11.5
11.19
10.98
11.44
11.52
10.37
10.64
10.38
11.78
12.91
13.24
Depreciation Expense
137
132
163
176
134
188
256
271
282
304
299
323
309
Net Income, GAAP
84
480
525
533
588
540
566
554
763
606
728
734
658
Effective Tax Rate (%)
30.76
13.62
12.84
12.86
4.04
12.53
12.29
12.78
6.53
13.23
11.35
13.49
13.17
Profit Margin (%)
1.45
8.34
8.61
8.7
9.18
8.18
7.82
7.97
10.38
6.91
10.44
10.6
9.74
Working Capital
282
193
352
547
464
621
658
898
1,464
1,280
1,325
1,128
1,117
LT Debt
1,282
1,271
2,012
1,867
1,728
2,120
2,430
2,560
3,164
2,475
2,475
2,538
2,560
Total Equity
1,968
2,236
2,790
3,094
3,573
4,034
4,562
4,656
5,601
6,224
6,523
6,487
5,954
Return on Invested Capital (%)
11.55
14.58
13.72
11.58
12.46
11.12
10.67
8.56
8.99
8.55
7.75
7.99
8.24
Return on Capital (%)
4.19
15.98
14.47
12.68
13.06
10.8
9.94
8.73
10.54
7.67
9
9.77
9
Return on Common Equity (%)
4.9
26.09
23.71
20.16
19.04
14.95
13.94
12.43
15.31
10.94
12.21
13.9
12.9

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.19%
5.49%
-8.23%
Free Cash Flow
3.33%
9.01%
-27.68%
Net Income, GAAP
3.41%
5.56%
-10.33%
Sales/Revenue/Turnover
1.51%
0.28%
-2.48%
Total Cash Common Dividend
10.18%
8.52%
4.87%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
6,975
2024
- -
- -
- -
- -
6,929
2025
- -
- -
- -
- -
6,758

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
4.1
2024
- -
- -
- -
- -
4.25
2025
- -
- -
- -
- -
4

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.08
2024
- -
- -
- -
- -
1.19
2025
- -
- -
- -
- -
1.31

Company Description

APIChat
CEO
Edmond Scanlon
Full Time Employees
21,461
Sector
Consumer Defensive
Industry
Packaged Foods
Address
Prince's Street Tralee Ireland V92 EH11
IPO Date
Jan 8, 2021
Business
Kerry Group plc (KRYAF) is a global leader in the development and manufacture of taste and nutrition solutions for the food, beverage, and pharmaceutical industries. The company provides a comprehensive portfolio of products and services, including taste modulation systems, functional ingredients such as emulsifiers, stabilizers, and texturants; nutrition solutions encompassing probiotics, proteins, and enzymes; and customized flavor profiles for categories like savory, sweet, beverages, and dairy. Kerry offers end-to-end services from research and development, application development, and technical support to supply chain optimization, serving multinational food and beverage manufacturers, quick-service restaurants, and pharmaceutical firms worldwide. Headquartered in Tralee, Ireland, and founded in 1972, Kerry Group operates over 150 manufacturing facilities across more than 30 countries in Europe, the Americas, Asia Pacific, and the Middle East, with a strong emphasis on sustainable sourcing and innovation-driven growth in high-growth markets like plant-based and health-focused products. In the last two years, Kerry has pursued strategic expansions including the acquisition of Biosearch Life in 2024 to bolster its natural ingredients and bioscience offerings; a major partnership with an industry-leading plant-based protein innovator announced in early 2025 to accelerate alternative protein solutions; and the launch of the Kerry Health and Nutrition Institute's expanded digital platform for personalized nutrition insights. The company also completed a significant funding round for its sustainability initiatives and reorganized its business segments into streamlined Taste and Nutrition divisions to enhance operational efficiency amid rising demand for clean-label products.

Company News

APIChat
  • Kerry Group plc (KRYAY) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript

  • Kerry Group plc (KRYAY) Q4 2025 Earnings Call Transcript

  • Kerry Group: Slowly Getting Attractive Again

  • Artisan Value Fund Q3 2025 Top Contributors And Detractors

  • Kerry Group plc (KRYAY) Q3 2025 Earnings Call Transcript

  • Kerry Group: Streamlining The Business After Selling The Dairy Division

  • Kerry Group: Gaining Momentum In Health And Wellness

  • Should You Bring The Luck Of The Irish To Your Investmets?

  • Kerry Group: Expect A Big EPS Increase By 2026